scholarly journals Updated Requirements for Measurement Quality and Quality Assurance of Point-Of-Care Testing (POCT) – Blood Glucose Measurement Systems with Unit-Use Reagents Suitable for the Initial Diagnosis of Diabetes Manifested in Pregnancy or Gestational Diabetes Mellitus (GDM) According to the GDM Guideline of the German Diabetes Association (DDG)

2015 ◽  
Vol 10 (04) ◽  
pp. E1-E3
Author(s):  
M. Neumaier ◽  
P. Luppa ◽  
T. Koschinsky ◽  
E. Siegel ◽  
G. Freckmann ◽  
...  
2013 ◽  
Vol 36 (2) ◽  
Author(s):  
Theodor Koschinsky ◽  
Peter B. Luppa

AbstractNew DDG (Deutsche Diabetes-Gesellschaft) and AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften) guidelines have been established for the diagnosis of diabetes mellitus and gestational diabetes. These are relevant for blood glucose (BG) measurements with reference to: distinction from HbA


2016 ◽  
Vol 11 (2) ◽  
pp. 296-298 ◽  
Author(s):  
Norbert Hermanns ◽  
Dominic Ehrmann ◽  
Bernhard Kulzer

This analytical comment discusses what standards are needed for the evaluation of the accuracy of glucose measurement systems continuously measuring glucose in the interstitial fluid. Since accuracy standards for continuous glucose monitoring (CGM)/flash glucose monitoring (FGM) systems are currently based on modeling studies or consensus of experts, we raised the question whether non-inferiority trials evaluating the safety and efficacy of CGM/FGM measurements compared to capillary blood glucose measurement with point-of-care devices could help to establish clarity about the needed accuracy standards of CGM/FGM. Such trials could also support the replacement of capillary blood glucose measurements by modern CGM/FGM systems.


2021 ◽  
Vol 1 (2) ◽  
pp. 1-8
Author(s):  
Peter Paul Mwinsanga Dapare

Background: Blood glucose measurement is a way of monitoring changes in glycaemia. Different point-of-care testing (POCT) glucose meters are on the market and hence there is an increase in variability of the results given by these meters. This study sought to measure the glycaemic variability using four different point-of-care glucose meters Methods: Four point of care glucometers namely; Accu-chek performer nano, OneTouch select plus flex, OneTouch Ultra 2 and Easy Check were used test blood samples from a total of 100 patients visiting the collection point of the Tamale Teaching Hospital Laboratory. A chemistry analyzer (Mindray BS 240 fully automated) was used as the reference method. Results: The median (interquartile range), Bland Altman Plot and Regression Equation were used to assess the agreement between the various meters and the reference method. The OneTouch Select plus had the least bias (-0.85) and the the OneTouch Ultra 2 had the highest bias (1.49). The OneTouch select had the best limits of agreement (-2.51 – 0.82) and the OneTouch Ultra 2 had the widest limits of agreement (-1.91 – 4.89) when compared to the reference method. Conclusion: OneTouch Select plus had the best agreement with the reference method and the OneTouch Ultra 2 had the least agreement with the reference method. Blood glucose meters should be used for the monitoring of blood glucose however, it should not be used as a diagnostic tool. Annals of Medical Laboratory Science (2021) 1(2), 1 - 8 Keywords: glucometer, point-of-care, blood glucose, glycaemia


Author(s):  
Adisu Kebede ◽  
Yenew Kebede ◽  
Adino Desale ◽  
Achamyeleh Mulugeta ◽  
Zelalem Yaregal ◽  
...  

No abstract available.


2010 ◽  
Vol 38 (1) ◽  
pp. 339
Author(s):  
Cornelia W. Hoedemaekers ◽  
Jacqueline M. T. Klein Gunnewiek ◽  
Johannes G. Van der Hoeven

2013 ◽  
Vol 42 (4) ◽  
pp. 405-423 ◽  
Author(s):  
Bente Flatland ◽  
Kathleen P. Freeman ◽  
Linda M. Vap ◽  
Kendal E. Harr

2012 ◽  
Vol 36 (3) ◽  
Author(s):  
Theodor Koschinsky ◽  
Peter B. Luppa

ZusammenfassungFür die Durchführung und Bewertung der Blutglukose (BG)-Messung bei der primären Diabetesdiagnostik sind neue DDG (Deutsche Diabetes-Gesellschaft)- und AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften)-Leitlinien-Standards festgelegt worden. Diese betreffen folgende Bereiche: Abgrenzung zur HbA


2021 ◽  
Vol 12 (2) ◽  
pp. 1306-1310
Author(s):  
Angelie Jessica Subbiah ◽  
Kavimani M ◽  
Mukilan Ramadoss ◽  
Prabhu K

At present, herbal plants and their biologically active components have acquired importance in diabetes mellitus (DM) management, which has spread worldwide. The current study was carried out to analyse the antidiabetic action of  Katakakhadiradi kashayam in streptozotocin administered diabetic rats. The study was done in wistar rats by inducing diabetes using streptozotocin and nicotinamide. Diabetic rats were given katakakhadiradi kashayam with various doses of 100, 200 and 300 mg/kg/b.wt for 14 days, and its efficacy was compared with glibenclamide drug. The hypoglycemic effect of this katakakhadiradi kashayam was tested by taking blood glucose measurement in experimental rats. The oxidative damage caused by streptozotocin was analysed by LPO levels and the antioxidants status was assessed by GSH levels, GPx, SOD and CAT activities in pancreatic tissues. The antidiabetic study of katakakhadiradi kashayam showed reduction in hyperglycemia by reducing the oxidative damage in pancreatic tissue and improving the antioxidants. Overall, the reports of the study showed that katakakhadiradi kashayam could be used to improve management of diabetic rats. The acquired data suggest the hypoglycemic efficacy of katakakhadiradi kashayam, which is practically a safe herbal formulation and may be used as a good alternative to cure diabetes mellitus.


Sign in / Sign up

Export Citation Format

Share Document